4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-035310
CEO and CFO bought 2,200 shares at an average $13.43 ($29,555)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2026-07-28 | Purchase | +1,500 | $13.59 | $20,385 | 5,610,702 | D |
| Patel Snehal CEO and CFO | 2026-07-29 | Purchase | +700 | $13.10 | $9,170 | 5,611,402 | D |
| Open-market purchases · 2,200 sh · avg $13.43 · $29,555 | |||||||
Loading xslF345X06/ownership.xml…